Serious Adverse Events in Randomized Psychosocial Treatment Studies

Safety or Arbitrary Edicts?

Nancy M. Petry, John M. Roll, Bruce J. Rounsaville, Samuel A. Ball, Maxine Stitzer, Jessica M. Peirce, Jack Blaine, Kimberly C. Kirby, Dennis McCarty, Kathleen M. Carroll

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Human subjects protection policies developed for pharmaceutical trials are now being widely applied to psychosocial intervention studies. This study examined occurrences of serious adverse events (SAEs) reported in multicenter psychosocial trials of the National Institute on Drug Abuse Clinical Trials Network. Substance-abusing participants (N = 1,687) were randomized to standard care or standard care plus either contingency management or motivational enhancement. Twelve percent of participants experienced 1 or more SAEs during the 27,198 person-weeks of follow-up. Of the 260 SAEs recorded, none were judged by the data safety monitoring board to be study related, and there were no significant differences between experimental and control conditions in SAE incidence rates. These data underscore the need to reconsider the rationale behind, and appropriate methods for, monitoring safety during psychosocial therapy trials.

Original languageEnglish (US)
Pages (from-to)1076-1082
Number of pages7
JournalJournal of Consulting and Clinical Psychology
Volume76
Issue number6
DOIs
StatePublished - Dec 2008

Fingerprint

National Institute on Drug Abuse (U.S.)
Clinical Trials Data Monitoring Committees
Drug and Narcotic Control
Standard of Care
Multicenter Studies
Clinical Trials
Safety
Incidence
Therapeutics

Keywords

  • good clinical practice
  • human subjects protection
  • participant safety
  • psychosocial treatments
  • serious adverse events

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Petry, N. M., Roll, J. M., Rounsaville, B. J., Ball, S. A., Stitzer, M., Peirce, J. M., ... Carroll, K. M. (2008). Serious Adverse Events in Randomized Psychosocial Treatment Studies: Safety or Arbitrary Edicts? Journal of Consulting and Clinical Psychology, 76(6), 1076-1082. https://doi.org/10.1037/a0013679

Serious Adverse Events in Randomized Psychosocial Treatment Studies : Safety or Arbitrary Edicts? / Petry, Nancy M.; Roll, John M.; Rounsaville, Bruce J.; Ball, Samuel A.; Stitzer, Maxine; Peirce, Jessica M.; Blaine, Jack; Kirby, Kimberly C.; McCarty, Dennis; Carroll, Kathleen M.

In: Journal of Consulting and Clinical Psychology, Vol. 76, No. 6, 12.2008, p. 1076-1082.

Research output: Contribution to journalArticle

Petry, NM, Roll, JM, Rounsaville, BJ, Ball, SA, Stitzer, M, Peirce, JM, Blaine, J, Kirby, KC, McCarty, D & Carroll, KM 2008, 'Serious Adverse Events in Randomized Psychosocial Treatment Studies: Safety or Arbitrary Edicts?', Journal of Consulting and Clinical Psychology, vol. 76, no. 6, pp. 1076-1082. https://doi.org/10.1037/a0013679
Petry, Nancy M. ; Roll, John M. ; Rounsaville, Bruce J. ; Ball, Samuel A. ; Stitzer, Maxine ; Peirce, Jessica M. ; Blaine, Jack ; Kirby, Kimberly C. ; McCarty, Dennis ; Carroll, Kathleen M. / Serious Adverse Events in Randomized Psychosocial Treatment Studies : Safety or Arbitrary Edicts?. In: Journal of Consulting and Clinical Psychology. 2008 ; Vol. 76, No. 6. pp. 1076-1082.
@article{a1fe6ecad7254091bd9d989ec28bede8,
title = "Serious Adverse Events in Randomized Psychosocial Treatment Studies: Safety or Arbitrary Edicts?",
abstract = "Human subjects protection policies developed for pharmaceutical trials are now being widely applied to psychosocial intervention studies. This study examined occurrences of serious adverse events (SAEs) reported in multicenter psychosocial trials of the National Institute on Drug Abuse Clinical Trials Network. Substance-abusing participants (N = 1,687) were randomized to standard care or standard care plus either contingency management or motivational enhancement. Twelve percent of participants experienced 1 or more SAEs during the 27,198 person-weeks of follow-up. Of the 260 SAEs recorded, none were judged by the data safety monitoring board to be study related, and there were no significant differences between experimental and control conditions in SAE incidence rates. These data underscore the need to reconsider the rationale behind, and appropriate methods for, monitoring safety during psychosocial therapy trials.",
keywords = "good clinical practice, human subjects protection, participant safety, psychosocial treatments, serious adverse events",
author = "Petry, {Nancy M.} and Roll, {John M.} and Rounsaville, {Bruce J.} and Ball, {Samuel A.} and Maxine Stitzer and Peirce, {Jessica M.} and Jack Blaine and Kirby, {Kimberly C.} and Dennis McCarty and Carroll, {Kathleen M.}",
year = "2008",
month = "12",
doi = "10.1037/a0013679",
language = "English (US)",
volume = "76",
pages = "1076--1082",
journal = "Journal of Consulting and Clinical Psychology",
issn = "0022-006X",
publisher = "American Psychological Association Inc.",
number = "6",

}

TY - JOUR

T1 - Serious Adverse Events in Randomized Psychosocial Treatment Studies

T2 - Safety or Arbitrary Edicts?

AU - Petry, Nancy M.

AU - Roll, John M.

AU - Rounsaville, Bruce J.

AU - Ball, Samuel A.

AU - Stitzer, Maxine

AU - Peirce, Jessica M.

AU - Blaine, Jack

AU - Kirby, Kimberly C.

AU - McCarty, Dennis

AU - Carroll, Kathleen M.

PY - 2008/12

Y1 - 2008/12

N2 - Human subjects protection policies developed for pharmaceutical trials are now being widely applied to psychosocial intervention studies. This study examined occurrences of serious adverse events (SAEs) reported in multicenter psychosocial trials of the National Institute on Drug Abuse Clinical Trials Network. Substance-abusing participants (N = 1,687) were randomized to standard care or standard care plus either contingency management or motivational enhancement. Twelve percent of participants experienced 1 or more SAEs during the 27,198 person-weeks of follow-up. Of the 260 SAEs recorded, none were judged by the data safety monitoring board to be study related, and there were no significant differences between experimental and control conditions in SAE incidence rates. These data underscore the need to reconsider the rationale behind, and appropriate methods for, monitoring safety during psychosocial therapy trials.

AB - Human subjects protection policies developed for pharmaceutical trials are now being widely applied to psychosocial intervention studies. This study examined occurrences of serious adverse events (SAEs) reported in multicenter psychosocial trials of the National Institute on Drug Abuse Clinical Trials Network. Substance-abusing participants (N = 1,687) were randomized to standard care or standard care plus either contingency management or motivational enhancement. Twelve percent of participants experienced 1 or more SAEs during the 27,198 person-weeks of follow-up. Of the 260 SAEs recorded, none were judged by the data safety monitoring board to be study related, and there were no significant differences between experimental and control conditions in SAE incidence rates. These data underscore the need to reconsider the rationale behind, and appropriate methods for, monitoring safety during psychosocial therapy trials.

KW - good clinical practice

KW - human subjects protection

KW - participant safety

KW - psychosocial treatments

KW - serious adverse events

UR - http://www.scopus.com/inward/record.url?scp=57649227258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649227258&partnerID=8YFLogxK

U2 - 10.1037/a0013679

DO - 10.1037/a0013679

M3 - Article

VL - 76

SP - 1076

EP - 1082

JO - Journal of Consulting and Clinical Psychology

JF - Journal of Consulting and Clinical Psychology

SN - 0022-006X

IS - 6

ER -